Concepts (214)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hospital Medicine | 7 | 2021 | 27 | 2.720 |
Why?
|
| Medical Overuse | 8 | 2022 | 25 | 2.010 |
Why?
|
| Hospitals, Pediatric | 12 | 2025 | 766 | 1.810 |
Why?
|
| Bronchiolitis | 6 | 2019 | 122 | 1.720 |
Why?
|
| Pediatrics | 12 | 2020 | 1157 | 1.520 |
Why?
|
| Hospitalists | 5 | 2021 | 45 | 1.490 |
Why?
|
| Child, Hospitalized | 2 | 2019 | 73 | 1.120 |
Why?
|
| Guideline Adherence | 4 | 2025 | 378 | 1.020 |
Why?
|
| Patient Readmission | 3 | 2020 | 385 | 0.960 |
Why?
|
| Pneumonia | 2 | 2018 | 325 | 0.880 |
Why?
|
| Medicine | 2 | 2024 | 99 | 0.880 |
Why?
|
| Community-Acquired Infections | 2 | 2017 | 241 | 0.880 |
Why?
|
| Quality of Health Care | 3 | 2018 | 392 | 0.820 |
Why?
|
| Child Health | 2 | 2024 | 55 | 0.810 |
Why?
|
| Quality Improvement | 4 | 2019 | 646 | 0.770 |
Why?
|
| Child | 30 | 2025 | 24559 | 0.630 |
Why?
|
| Adolescent Health | 1 | 2019 | 14 | 0.620 |
Why?
|
| Benchmarking | 2 | 2017 | 137 | 0.620 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 196 | 0.590 |
Why?
|
| Adrenergic beta-2 Receptor Agonists | 1 | 2018 | 62 | 0.590 |
Why?
|
| Forced Expiratory Volume | 1 | 2018 | 171 | 0.580 |
Why?
|
| Habits | 1 | 2018 | 26 | 0.580 |
Why?
|
| Asthma | 3 | 2020 | 756 | 0.550 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2018 | 112 | 0.550 |
Why?
|
| Practice Guidelines as Topic | 6 | 2025 | 1273 | 0.550 |
Why?
|
| Standard of Care | 1 | 2018 | 130 | 0.540 |
Why?
|
| Quality Assurance, Health Care | 1 | 2018 | 208 | 0.540 |
Why?
|
| Cannula | 1 | 2017 | 27 | 0.530 |
Why?
|
| Oximetry | 1 | 2017 | 171 | 0.510 |
Why?
|
| Patient Handoff | 1 | 2016 | 24 | 0.510 |
Why?
|
| Insurance, Health | 1 | 2016 | 139 | 0.500 |
Why?
|
| Hypoxia | 1 | 2017 | 250 | 0.490 |
Why?
|
| Hospitalization | 6 | 2025 | 1790 | 0.480 |
Why?
|
| Patient Satisfaction | 1 | 2018 | 476 | 0.480 |
Why?
|
| Pneumonia, Bacterial | 1 | 2015 | 77 | 0.460 |
Why?
|
| Patient Discharge | 1 | 2018 | 496 | 0.450 |
Why?
|
| Humans | 49 | 2025 | 125667 | 0.450 |
Why?
|
| Bacteremia | 2 | 2015 | 407 | 0.440 |
Why?
|
| Career Choice | 1 | 2015 | 148 | 0.430 |
Why?
|
| Patient Safety | 1 | 2018 | 400 | 0.430 |
Why?
|
| Disease Management | 1 | 2017 | 532 | 0.410 |
Why?
|
| Primary Health Care | 1 | 2019 | 777 | 0.400 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 635 | 0.400 |
Why?
|
| Diagnostic Errors | 2 | 2015 | 334 | 0.390 |
Why?
|
| Choice Behavior | 1 | 2013 | 132 | 0.390 |
Why?
|
| Caregivers | 2 | 2021 | 578 | 0.370 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 197 | 0.370 |
Why?
|
| Medication Adherence | 1 | 2015 | 400 | 0.360 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 1026 | 0.360 |
Why?
|
| Venous Thrombosis | 1 | 2012 | 184 | 0.340 |
Why?
|
| Leukocytosis | 1 | 2009 | 46 | 0.320 |
Why?
|
| Osteomyelitis | 1 | 2012 | 208 | 0.320 |
Why?
|
| Drug Eruptions | 1 | 2009 | 32 | 0.320 |
Why?
|
| Gout Suppressants | 1 | 2009 | 62 | 0.310 |
Why?
|
| Allopurinol | 1 | 2009 | 71 | 0.310 |
Why?
|
| Eosinophilia | 1 | 2009 | 101 | 0.290 |
Why?
|
| Child, Preschool | 11 | 2025 | 14106 | 0.290 |
Why?
|
| Infant | 9 | 2021 | 12572 | 0.270 |
Why?
|
| Adolescent | 12 | 2021 | 19441 | 0.270 |
Why?
|
| Infant, Newborn | 8 | 2021 | 8249 | 0.260 |
Why?
|
| Length of Stay | 3 | 2020 | 1313 | 0.240 |
Why?
|
| Oseltamivir | 1 | 2025 | 16 | 0.240 |
Why?
|
| HIV | 2 | 2003 | 180 | 0.240 |
Why?
|
| Receptors, CCR5 | 1 | 2003 | 29 | 0.210 |
Why?
|
| Fecal Impaction | 1 | 2022 | 9 | 0.200 |
Why?
|
| Lentivirus | 1 | 2002 | 82 | 0.200 |
Why?
|
| Health Services Misuse | 1 | 2022 | 27 | 0.190 |
Why?
|
| Sports Medicine | 1 | 2022 | 28 | 0.190 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 3 | 2022 | 225 | 0.190 |
Why?
|
| Physical Examination | 2 | 2022 | 159 | 0.190 |
Why?
|
| Polypharmacy | 1 | 2021 | 40 | 0.190 |
Why?
|
| Gastroenteritis | 3 | 2019 | 349 | 0.180 |
Why?
|
| Gene Transfer Techniques | 1 | 2002 | 358 | 0.180 |
Why?
|
| Female | 12 | 2025 | 66998 | 0.180 |
Why?
|
| Hypertension | 1 | 2009 | 1332 | 0.180 |
Why?
|
| Male | 12 | 2025 | 61776 | 0.170 |
Why?
|
| Metered Dose Inhalers | 1 | 2020 | 12 | 0.170 |
Why?
|
| Status Asthmaticus | 1 | 2020 | 20 | 0.170 |
Why?
|
| Magnesium | 1 | 2020 | 123 | 0.170 |
Why?
|
| Radiography, Thoracic | 2 | 2018 | 152 | 0.170 |
Why?
|
| Certification | 1 | 2020 | 67 | 0.160 |
Why?
|
| Blood Transfusion | 1 | 2022 | 313 | 0.160 |
Why?
|
| Administration, Intravenous | 1 | 2020 | 143 | 0.160 |
Why?
|
| Antiviral Agents | 1 | 2025 | 767 | 0.160 |
Why?
|
| Medically Unexplained Symptoms | 1 | 2019 | 10 | 0.160 |
Why?
|
| Medication Errors | 1 | 2021 | 187 | 0.160 |
Why?
|
| Clinical Competence | 3 | 2020 | 1009 | 0.160 |
Why?
|
| Patient Care | 1 | 2020 | 100 | 0.160 |
Why?
|
| Laboratories, Hospital | 1 | 2019 | 20 | 0.160 |
Why?
|
| Electrolytes | 1 | 2019 | 53 | 0.160 |
Why?
|
| Radiography | 2 | 2018 | 824 | 0.160 |
Why?
|
| Literacy | 1 | 2019 | 15 | 0.160 |
Why?
|
| Respiratory Tract Diseases | 1 | 2019 | 75 | 0.160 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2025 | 735 | 0.160 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 60 | 0.150 |
Why?
|
| Rehydration Solutions | 1 | 2018 | 8 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2002 | 940 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2025 | 662 | 0.150 |
Why?
|
| Pregnancy in Adolescence | 1 | 2019 | 50 | 0.150 |
Why?
|
| Staff Development | 1 | 2018 | 44 | 0.150 |
Why?
|
| United States | 6 | 2025 | 10942 | 0.150 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2019 | 140 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 126 | 0.140 |
Why?
|
| Curriculum | 2 | 2020 | 727 | 0.140 |
Why?
|
| Antimicrobial Stewardship | 1 | 2019 | 84 | 0.140 |
Why?
|
| Child Health Services | 1 | 2018 | 87 | 0.140 |
Why?
|
| Respiratory Tract Infections | 1 | 2019 | 274 | 0.130 |
Why?
|
| Electrocardiography | 1 | 2022 | 978 | 0.130 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2017 | 91 | 0.130 |
Why?
|
| Retrospective Studies | 6 | 2020 | 16417 | 0.130 |
Why?
|
| Feasibility Studies | 1 | 2018 | 762 | 0.120 |
Why?
|
| Lymphadenitis | 1 | 2015 | 26 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1333 | 0.120 |
Why?
|
| Faculty, Medical | 1 | 2018 | 262 | 0.120 |
Why?
|
| Failure to Thrive | 1 | 2015 | 90 | 0.120 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2015 | 81 | 0.120 |
Why?
|
| Mental Disorders | 1 | 2022 | 829 | 0.120 |
Why?
|
| Pedigree | 1 | 2018 | 1608 | 0.110 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 1070 | 0.110 |
Why?
|
| Aftercare | 1 | 2015 | 149 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2018 | 1397 | 0.110 |
Why?
|
| Treatment Outcome | 3 | 2019 | 12420 | 0.110 |
Why?
|
| Personnel, Hospital | 1 | 2014 | 34 | 0.110 |
Why?
|
| Oxygen | 1 | 2017 | 557 | 0.110 |
Why?
|
| Pediatricians | 2 | 2025 | 69 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2014 | 266 | 0.100 |
Why?
|
| Physician's Role | 1 | 2014 | 168 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2014 | 383 | 0.100 |
Why?
|
| Fever | 2 | 2015 | 299 | 0.090 |
Why?
|
| Steroids | 1 | 2012 | 203 | 0.090 |
Why?
|
| Evidence-Based Practice | 1 | 2012 | 112 | 0.090 |
Why?
|
| Leadership | 1 | 2014 | 230 | 0.090 |
Why?
|
| Communication | 1 | 2015 | 517 | 0.090 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 299 | 0.090 |
Why?
|
| Bronchodilator Agents | 1 | 2012 | 151 | 0.090 |
Why?
|
| Cohort Studies | 2 | 2019 | 4843 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2022 | 2434 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 3439 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2012 | 180 | 0.080 |
Why?
|
| Transaminases | 1 | 2009 | 32 | 0.080 |
Why?
|
| C-Reactive Protein | 1 | 2012 | 433 | 0.080 |
Why?
|
| Disease Progression | 1 | 2015 | 2089 | 0.080 |
Why?
|
| Societies, Medical | 1 | 2013 | 699 | 0.080 |
Why?
|
| Methylprednisolone | 1 | 2009 | 93 | 0.080 |
Why?
|
| Quality of Life | 1 | 2019 | 1952 | 0.080 |
Why?
|
| Mutation | 1 | 2003 | 5893 | 0.080 |
Why?
|
| Critical Illness | 1 | 2012 | 601 | 0.070 |
Why?
|
| Cell Line | 2 | 2003 | 2760 | 0.070 |
Why?
|
| Fluid Therapy | 2 | 2018 | 129 | 0.070 |
Why?
|
| Hospitals, Community | 2 | 2020 | 55 | 0.070 |
Why?
|
| Comorbidity | 1 | 2012 | 1537 | 0.070 |
Why?
|
| Time Factors | 1 | 2017 | 6351 | 0.070 |
Why?
|
| Syndrome | 1 | 2009 | 1121 | 0.070 |
Why?
|
| Pregnancy | 1 | 2019 | 7223 | 0.060 |
Why?
|
| Risk Factors | 3 | 2019 | 10340 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2016 | 1186 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2022 | 1122 | 0.060 |
Why?
|
| DNA Footprinting | 1 | 2003 | 14 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 1 | 2003 | 149 | 0.050 |
Why?
|
| New York | 1 | 2022 | 68 | 0.050 |
Why?
|
| Dosage Forms | 1 | 2021 | 9 | 0.050 |
Why?
|
| Medication Reconciliation | 1 | 2021 | 15 | 0.050 |
Why?
|
| Drug Storage | 1 | 2021 | 17 | 0.050 |
Why?
|
| DNA Primers | 1 | 2003 | 658 | 0.050 |
Why?
|
| Pamphlets | 1 | 2021 | 23 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2002 | 188 | 0.050 |
Why?
|
| Communication Barriers | 1 | 2021 | 38 | 0.050 |
Why?
|
| Athletes | 1 | 2022 | 66 | 0.050 |
Why?
|
| Nonprescription Drugs | 1 | 2021 | 50 | 0.050 |
Why?
|
| Forecasting | 1 | 2002 | 354 | 0.050 |
Why?
|
| Pneumothorax | 1 | 2022 | 76 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2003 | 836 | 0.040 |
Why?
|
| Cell Membrane | 1 | 2003 | 462 | 0.040 |
Why?
|
| Health Literacy | 1 | 2021 | 80 | 0.040 |
Why?
|
| Language | 1 | 2021 | 199 | 0.040 |
Why?
|
| Tonsillectomy | 1 | 2022 | 99 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2021 | 729 | 0.040 |
Why?
|
| Medicaid | 1 | 2022 | 243 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2003 | 1082 | 0.040 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2022 | 259 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2003 | 1590 | 0.040 |
Why?
|
| Health Personnel | 1 | 2024 | 509 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 2003 | 2714 | 0.040 |
Why?
|
| Base Sequence | 1 | 2003 | 3108 | 0.040 |
Why?
|
| Inpatients | 1 | 2022 | 500 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2002 | 688 | 0.040 |
Why?
|
| Ankle Injuries | 1 | 2018 | 33 | 0.040 |
Why?
|
| Education | 1 | 2018 | 109 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 3896 | 0.040 |
Why?
|
| Models, Biological | 1 | 2003 | 1468 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2020 | 323 | 0.040 |
Why?
|
| Patient Harm | 1 | 2017 | 5 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2018 | 195 | 0.030 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2020 | 479 | 0.030 |
Why?
|
| Mass Screening | 1 | 2022 | 787 | 0.030 |
Why?
|
| Urography | 1 | 2015 | 31 | 0.030 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 296 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2015 | 58 | 0.030 |
Why?
|
| Parents | 1 | 2021 | 1026 | 0.030 |
Why?
|
| Education, Medical | 1 | 2018 | 289 | 0.030 |
Why?
|
| Interinstitutional Relations | 1 | 2012 | 20 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 309 | 0.030 |
Why?
|
| Physical Therapy Modalities | 1 | 2012 | 52 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 163 | 0.020 |
Why?
|
| Program Development | 1 | 2012 | 185 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 220 | 0.020 |
Why?
|
| Food Hypersensitivity | 1 | 2014 | 153 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2060 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 2178 | 0.020 |
Why?
|
| Students, Medical | 1 | 2014 | 357 | 0.020 |
Why?
|
| Depression | 1 | 2018 | 1239 | 0.020 |
Why?
|
| Acute Disease | 1 | 2012 | 1111 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2019 | 6171 | 0.020 |
Why?
|
| Animals | 1 | 2002 | 34349 | 0.010 |
Why?
|